Although the TRiC has a potential role in cancer development by modulating the folding of client proteins related to oncogenesis, cell cycle and cytoskeleton (i.e. actin and tubulin) (Roh et al, 2015), a direct role in genome stability of stem cells is still missing. The gene discussed is MARVELD2; the disease is cancer.